Literature DB >> 23801520

Current Concepts and Controversies in Foregut Motility: the 2012 Kelly and Carlos Pellegrini SSAT/SAGES Joint Symposium.

Jeffrey B Matthews1, W Scott Melvin.   

Abstract

The 2012 Kelley and Carlos Pellegrini SSAT/SAGES Joint Symposium covered the topic "Current Concepts and Controversies in Foregut Motility". This article summarizes the high points of this session, which included the diagnosis and management of achalasia, gastroparesis, and biliary dyskinesia.

Entities:  

Mesh：

Year:  2013        PMID： 23801520     DOI： 10.1007/s11605-013-2256-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


  6 in total

Review 1.  Gastroparesis: what is the current state-of-the-art for evaluation and medical management? What are the results?

Authors:  Allen Lee
Journal:  J Gastrointest Surg       Date:  2013-06-26       Impact factor: 3.452

Review 2.  Biliary dyskinesia: does it exist? If so, how do we diagnose it? Is laparoscopic cholecystectomy effective or a sham operation?

Authors:  David B Adams
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

3.  Technical pearls in achalasia.

Authors:  Barry Salky
Journal:  J Gastrointest Surg       Date:  2013-07-11       Impact factor: 3.452

Review 4.  Sphincter of Oddi dysfunction: how is it diagnosed? How is it classified? How do we treat it medically, endoscopically, and surgically?

Authors:  Attila Nakeeb
Journal:  J Gastrointest Surg       Date:  2013-07-17       Impact factor: 3.452

Review 5.  Surgical management of gastroparesis: gastrostomy/jejunostomy tubes, gastrectomy, pyloroplasty, gastric electrical stimulation.

Authors:  Edward C Borrazzo
Journal:  J Gastrointest Surg       Date:  2013-08-14       Impact factor: 3.452

Review 6.  What is the best primary therapy for achalasia: medical or surgical treatment? Who owns achalasia?

Authors:  Marco E Allaix; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2013-06-19       Impact factor: 3.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.